Emergent Biosolutions Inc. Revenue Growth

Revenue Growth of EBS for past 10 years: annual, quarterly and twelve month trailing (TTM) including Revenue Growth growth rates and interactive chart. Year over year growth in total sales.

Highlights and Quick Summary

  • Revenue Growth for the quarter ending June 30, 2023 was 0.39 (a -184.71% decrease compared to previous quarter)
  • Year-over-year quarterly Revenue Growth decreased by -245.03%
  • Annual Revenue Growth for 2022 was -0.37 (a -345.54% decrease from previous year)
  • Annual Revenue Growth for 2021 was 0.15 (a -62.44% decrease from previous year)
  • Annual Revenue Growth for 2020 was 0.41 (a -1.76% decrease from previous year)
  • Twelve month Revenue Growth ending June 30, 2023 was -0.33 (a -25.55% decrease compared to previous quarter)
  • Twelve month trailing Revenue Growth increased by 291.81% year-over-year
Trailing Revenue Growth for the last four month:
30 Jun '23 31 Mar '23 31 Dec '22 30 Sep '22
-0.33 -0.44 -0.37 -0.08
Visit stockrow.com/EBS for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Revenue Growth of Emergent Biosolutions Inc.

Most recent Revenue Growthof EBS including historical data for past 10 years.

Interactive Chart of Revenue Growth of Emergent Biosolutions Inc.

Emergent Biosolutions Inc. Revenue Growth for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2023 0.39 -0.46 – – –
2022 -0.54 -0.27 -0.39 -0.1 -0.37
2021 0.24 -0.15 0.01 0.78 0.15
2020 0.62 0.24 0.62 0.01 0.41
2019 0.33 0.8 0.1 0.62 0.41
2018 0.4 0.16 1.19 0.01 0.39
2017 0.28 0.05 0.1 0.13 0.15
2016 0.07 -0.1 -0.28 0.62 -0.0
2015 0.38 0.15 0.14 0.18 0.21
2014 0.04 0.55 0.34 0.25 0.29
2013 0.04 0.34 0.17 -0.14 0.11
2012 -0.12 0.13 – – 0.03

Business Profile of Emergent Biosolutions Inc.

Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic
© stockrow.com